Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles
  • Search Articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease
Paige N. Spencer, Monica E. Brown, Erin P. Smith, Jiawei Wang, William Kim, Luisella Spiga, Naila Tasneem, Alan J. Simmons, Taewoo Kim, Yilin Yang, Yanwen Xu, Lin Zheng, James Ro, Harsimran Kaur, Seung Woo Kang, Matthew D. Helou, Mason A. Lee, Deronisha Arceneaux, Katherine D. Mueller, Ozge S. Kuddar, Mariah H. Harned, Jing Li, Amrita Banerjee, Nicholas O. Markham, Keith T. Wilson, Lori A. Coburn, Jeremy A. Goettel, Qi Liu, M. Kay Washington, Raphael H. Valdivia, Wenhan Zhu, Ken S. Lau
Paige N. Spencer, Monica E. Brown, Erin P. Smith, Jiawei Wang, William Kim, Luisella Spiga, Naila Tasneem, Alan J. Simmons, Taewoo Kim, Yilin Yang, Yanwen Xu, Lin Zheng, James Ro, Harsimran Kaur, Seung Woo Kang, Matthew D. Helou, Mason A. Lee, Deronisha Arceneaux, Katherine D. Mueller, Ozge S. Kuddar, Mariah H. Harned, Jing Li, Amrita Banerjee, Nicholas O. Markham, Keith T. Wilson, Lori A. Coburn, Jeremy A. Goettel, Qi Liu, M. Kay Washington, Raphael H. Valdivia, Wenhan Zhu, Ken S. Lau
View: Text | PDF
Research Article Cell biology Gastroenterology Inflammation

Pathobiont-triggered induction of goblet cell response drives regional susceptibility to inflammatory bowel disease

  • Text
  • PDF
Abstract

The gastrointestinal tract varies in structure and function by region, yet the drivers of region-specific inflammatory disease remain elusive. Here, a TNF-overexpressing murine model (TnfΔARE/+) of Crohn’s disease (CD) was used to investigate how pathobionts interact with host immune susceptibilities to drive region-specific disease. We identified the pathobiont Chlamydia muridarum, an intracellular bacterium and murine counterpart to the human sexually transmitted C. trachomatis, as a necessary and sufficient trigger for disease manifestation in the proximal/ascending colon, a common site of CD. In genetically susceptible hosts, pathobiont-triggered proximal colonic inflammation is driven by goblet cell responses, including tryptophan metabolism via indoleamine 2,3-dioxygenase 1 (IDO1). Our findings translate to human disease, where we demonstrate upregulation of epithelia-derived IDO1 in actively inflamed ascending colon specimens, but not actively inflamed terminal ileum specimens, of patients with CD. Our findings mechanistically reveal how genetic and microbial factors drive the manifestation of disease in a region-specific manner and provide a unique model to study CD specific to the ascending colon.

Authors

Paige N. Spencer, Monica E. Brown, Erin P. Smith, Jiawei Wang, William Kim, Luisella Spiga, Naila Tasneem, Alan J. Simmons, Taewoo Kim, Yilin Yang, Yanwen Xu, Lin Zheng, James Ro, Harsimran Kaur, Seung Woo Kang, Matthew D. Helou, Mason A. Lee, Deronisha Arceneaux, Katherine D. Mueller, Ozge S. Kuddar, Mariah H. Harned, Jing Li, Amrita Banerjee, Nicholas O. Markham, Keith T. Wilson, Lori A. Coburn, Jeremy A. Goettel, Qi Liu, M. Kay Washington, Raphael H. Valdivia, Wenhan Zhu, Ken S. Lau

×

Figure 4

C. muridarum colonization induces IDO1 expression in PC goblet cells.

Options: View larger image (or click on image) Download as PowerPoint

C. muridarum colonization induces IDO1 expression in PC goblet cells.
(...
(A and B) UMAP coembedding of scRNA-seq data from PC epithelial cells from CONV WT (N = 3), CONV young TnfΔARE/+ (N = 4), CONV aged TnfΔARE/+ (N = 4), SPF-B WT (N = 4), and SPF-B young TnfΔARE/+ (N = 5) mice with sample type overlay (A) and cell type (B) overlay. (C and D) Cell type proportions from scRNA-seq data in B grouped by sample type. Statistical significance was determined using multiple unpaired 2-tailed t tests between 3 pairwise comparisons with FDR of 1%. Only statistically significant results are shown. *P < 0.05. (E) Gene Ontology of Biological Process terms derived from ORA of upregulated genes in cells from the SPF-B facility (top) or CONV facility (bottom). Enrichment ratio is shown, and statistical significance was determined using FDR < 0.05. (F) Cell type–specific expression of genes selected from those reaching statistical enrichment in ORA from E and from select marker genes for surface goblet cells, progenitors, and goblet cells. (G) Cell type–specific expression of Ido1 from data in A and B. (H) Representative IF images of IDO1, Chlamydia MOMP, and nuclei costaining on PC sections from age-matched (34–42 weeks) WT and TnfΔARE/+ mice from the SPF-B and CONV facilities. N = 3 mice per condition. Data in top right image first appear as nuclei/MOMP costaining (no IDO1) in Supplemental Figure 2G. (I) Quantitative analysis of images in H. Statistical significance was determined using an ordinary 1-way ANOVA with Šidák’s multiple-comparison test. ***P < 0.001. (J) Representative IF images, with insets, of IDO1, UEA1 lectin, and nuclei costaining on PC sections from age-matched (16–17 weeks) WT and TnfΔARE/+ mice from the CONV facility. Dashed white lines indicate border between epithelial surface and lumen. N = 3 mice per condition. Original magnification, ×20. (K) Quantitative analysis of images in J. Statistical significance was determined using an unpaired 2-tailed t test. All scale bars: 100 μm. Data are shown as the mean ± SEM in quantifications. See also Supplemental Figures 5 and 6, and Supplemental Tables 4–7.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts